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ABSTRACT: A new dual hepatocyte-targeting fluorescent probe HPL-1, which can 
precisely distinguish tumorous pH from physiological pH, was developed. The OFF-
ON switch of HPL-1 can be triggered via pH-induced structural change of the lactam 
group of the rhodamine moiety from closed-ring to open-ring. Our results showed that 
the phosphate group of HPL-1 is beneficial to its accumulation in liver cells, and 
combination of the phosphate and galactose units could synergistically increase the 
hepatocyte-targeting capacity. HPL-1 could selectively distinguish hepatoma cells 
from other tissue cells, and precisely distinguish cancerous liver cells from normal liver 
cells. Compared with other reported probes, HPL-1 not only enable a simple and 
convenient detection method, but also has good hepatocyte-targeting capacity and 
precise recognition capacity of tumors under weak acid micro-environment, which 
opens new avenues for precise diagnosis and treatment of hepatocellular carcinoma. 
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1. Introduction 
Hepatocellular carcinoma (HCC) is one of the most dangerous malignancies 
associated with high incidence and low survival rate1, 2. HCC is often diagnosed at the 
advanced stage3, when the surgical removal is not applicable any more. Therefore, 
considerable efforts have been devoted to the early and accurate detection of HCC, and 
a series of biomarkers have been developed for the specific recognition of HCC4. 
However, while these methods could partially identify cancer cells, they suffer from 
some drawbacks such as the complex pretreatment, high cost, time-consuming, or 
difficult for storing.    
It has been well-known that the pH value of tumorous micro-environment 
(6.2~6.9)5,6 is slightly lower than that of physiological micro-environment 
(7.2~7.4)7and this phenomenon has arisen from the unlimited propagation of cancer 
cells in the oxygen-deficient environment. Therefore, precise differentiation of the 
subtle pH value change would provide an ideal and practical approach to distinguish 
cancerous cells from normal cells. Rhodamines8-11, naphthalimides12,13, benzoindole14-
16, and a series of nanomaterials17 are well-established pH-responsive probes with good 
optical performance, spatial-temporal feature, high sensitivity and selectivity18. 
However, they are mainly used to monitor pH changes under acidic conditions (pH < 
5.5). Currently, there are no a small molecule probes able to accurately differentiate pH 
values of cancer cells from normal cells.    
It has been well-documented that galactose can be recognized by 
asialoglycoprotein receptor (ASGPR) overexpressed on the hepatocytes19-24. On 
the other hand, organic molecules bearing a phosphate or phosphoric acid group such 
as Sofosbuvir and Adefovir were found to easily accumulate in liver (ProTide 
technology)25,26. However, the hepatocyte-targeting capacity of either galactose or 
phosphate is still unsatisfactory. In our efforts to develop a simple, efficient, and 
accurate method to distinguish cancerous liver cells from normal liver cells, galactose 
and phosphate have been integrated in this study as a dual hepatocyte-targeting motif 
with the rhodamine derivative as a pH-responsive fluorophore. On the basis of this, a 
novel small molecule dual hepatocyte-targeting probe (HPL-1) for specific detection 
of HCC has been developed for the first time (Fig. 1). 
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Fig. 1. Structure of HPL-1 
2. Experimental Section 
2.1. Materials and Instruments.  
All reactants were commercially purchased without further purification. Phenyl 
dichlorophosphate is purchased from Damas-beta (China). 2-(4-Diethylamino)-2-
hydroxybenzoyl) benzoic acid and Dimethylcarbamoyl chloride was purchased from 
Jiuding Chemical (Shanghai, China). β-Galactose were obtained from Xilong Chemical 
(Guangdong, China). Resorcinol is acquired from Damao Chemical (Tianjin, China). 
Ethanolamine is supplied by Sinopharm Group Chemicals (Shanghai, China).1H NMR 
and 13C NMR spectra were recorded on a Bruker 600 MHz (Switzerland) at 25 °C, with 
TMS as the internal standard in CDCl3, and the solvent peak as the internal reference 
in CD3OD. MS analysis was performed with a Thermo Fisher Scientific LTQ FT Ultra 
(USA). The UV-vis absorption and fluorescence spectra were obtained with a Shanghai 
JingHua 7600 UV-visible spectrophotometer (dual beam) (China) and a Shimadzu RF-
5301PC (Japan) at room temperature, respectively. The cytotoxicity assays were 
conducted using ELX800 absorbance microplate reader. Cell image assays were 
performed by Multi-photon laser confocal scanning microscopy (a LEICA-TCS-
SP8MP) (Germany).  
2.2. Synthesis of HPL-1.  
Synthesis of HPL-1 commenced with the cyclization of 2-(4-diethylamino)-2-
hydroxybenzoyl)benzoic acid and resorcinol under acidic conditions to give a 
rhodamine derivatives 127. Esterification of this compound with dimethylcarbamoyl 
chloride afforded the carbamate compound 2. Treatment of compound 2 with 
ethanolamine provided the amide compound 3 which was subsequently converted to 
the phosphate compound 6 with phenyl dichlorophosphate followed by the primary 
amine 5. Then, the alkyne compound 6 underwent a click reaction to generate the 
triazole compound 8 which provided the desired molecule HPL-1 upon saponification 
(Scheme 1). The structures of all compounds were characterized by 1H NMR, 13C NMR, 
and MS spectrometry (Supplementary Information). 
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Scheme 1. The synthesis of HPL-1. 
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(a) CF3COOH, 90°C, Reflux for 24h, (95%) (b) Dimethylcarbamoyl chloride, KOH, DMF (50%) 
(c) Ethanolamine, C2H5OH, 90°C, Reflux (43%) (d) Phenyl dichlorophosphate, Et3N, DCM, -40 °C 
(e) Compound 5, Et3N, DCM, -40 °C (58%) (f) Compound 7, NaVc, CuSO4.5H2O, THF: H2O 
(v:v=1:1), (89%) (g) CH3ONa, CH3OH (95%). 
2.3. Spectral testing  
The probe HPL-1 was dissolved in DMSO to prepare a 1 mM stock solution. Take 
100 μL stock solution in a 5 mL centrifuge tube, then set the volume to 5 mL with 
different pH buffer solution to form 20 μM HPL-1 solution. The test solution is poured 
into the cuvette. UV spectral scanning range is 200 nm-800 nm. Fluorescence spectrum 
scanning range is 300 nm-700 nm. Slit width is 3 nm×3 nm. 
2.4. Cell culture and Confocal Microscopy Imaging 
HepG2 cells were incubated with 20 μM HPL-1 for 30 min at 37°C. Then, the cells 
were washed with PBS for three times and fixed with 4% paraformaldehyde for 15 min 
at room temperature. After washing with PBS for three times, the cells were soaked in 
buffer solution (pH 6.5) and buffer solution (pH 7.4) for 10 min, respectively.  
HepG2 cells were incubated with 20 μM HPL-1 for 30 min at 37°C. Then, the cells 
were washed with PBS for three times and fixed with 4% paraformaldehyde for 15 min. 
After washing with PBS for three times, HepG2 cells were soaked in buffer solution 
(pH 6.5) for 10 min, and L02 cells were soaked in buffer solution (pH 7.4) for 10 min.  
HepG2, A549, SGC-7901 and Hela cells were treated with 20 μM HPL-1 for 30 min 
at 37°C. Subsequently, the cells were washed with PBS for three times and fixed with 
4% paraformaldehyde for 15 min. After washing with PBS for three times, the cells 
were soaked in buffer solution (pH 6.5) for 10 min.  
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HepG2 cells were incubated with 20 μM Compound 3 (without phosphate group and 
gatactose group), Compound 6 (with phosphate group) and HPL-1 (with phosphate and 
gatactose groups) for 30 min at 37°C, respectively. Subsequently, the cells were washed 
with PBS for three times and fixed with 4% paraformaldehyde for 15 min. After 
washing with PBS for three times, the cells were treated by buffer solution (pH 6.5) for 
10 min. 
To illuminate localization of HPL-1 in lysosome, HepG2 cells were seeded in glass 
bottom dish to incubate for 24 h at 37 °C under 5% CO2. Then, the cells were incubated 
with LysoTracker (500 nM) for 30 min. Next, the cells were washed by PBS for three 
times and treated by HPL-1 (20 μM) for another 30 min. Finally, the cells were washed 
thrice with PBS.  
All fluorescence images were collected with Multi-photon laser confocal scanning 
microscopy (Germany). Probes were excited at 488 nm and their green emissions were 
collected in the range of 490−530 nm. More experimental details were shown in the 
results and discussion.  
2.5 Cytotoxicity assays.  
HepG2 cells were seeded in 96-well plates with a density of 6000 cells per well and 
incubated for 24 h at 37 °C under 5% CO2. Then, the cells were treated with the 
different concentrations of HPL-1 (0-20 μM) for 48 h. Subsequently, 10 μL MTT (5 
mg/ml) was added to incubate for 4 h. After that, the medium was replaced by 150 μL 
DMSO. After gentle shaking for 10 min, and the OD values were recorded by an 
ELX800 absorbance plate reader (USA) at 490 nm. 
 
3. Results and Discussion 
3.1. Spectral Properties of HPL-1 at Different pH Values 
To explore the sensitivity of HPL-1 toward the pH values, the fluorescence titration 
experiments were carried out (Fig. 2). It was noticed that the fluorescence spectra of 
HPL-1 solution shows two distinct peaks at pH 6.5 and pH 7.4. Additionally, the 
fluorescence intensity of this compound at pH 6.5 is obviously stronger than that at pH 
7.4. Presumably, HPL-1 adopts a non-conjugated closed-ring lactam conformation at 
pH 7.4 with weak fluorescence from the rhodamine moiety. Once the pH value is 
decreased to 6.5, the lactam ring of HPL-1 could be opened to give an extended 
conjugated system with strong fluorescent28, 29. Clearly, HPL-1 is a highly pH-sensitive 
probe in the narrow range of pH 6.0~7.5, and is capable of monitoring the pH change 
in weak acidic environment. Thus, HPL-1 has the potential to distinguish cancer cells 
with the pH value of 6.2~6.9 from normal cells (pH 7.2~7.4). To illuminate the effect 
of phosphate group of HPL-1 on the sensitivity toward the pH values, the fluorescence 
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properties of Compound 3 without phosphate group toward the pH value were 
comparatively analyzed (Fig. S1). From Fig. S1 and Fig. 2, HPL-1 and Compound 3 
present similar fluorescence tendency, but HPL-1 shows stronger fluorescence 
intensity than Compound 3, suggesting that the introduction of phosphate group does 
not modify detection range of pH values (6.0~7.5), but it is beneficial for the sensitivity 
toward the pH value.   
 
Fig. 2. Fluorescence intensity (FI) of HPL-1 (20 μM) at different pH values in Britton−Robinson 
(BR) buffer solution. λ ex = 273 nm, λ em = 544nm. Slit width: 3nm×3 nm. 
3.2. Cellular pH sensitivity of HPL-1 at pH 6.5 and 7.4  
To further explore whether HPL-1 can accurately distinguish weak acid environment 
of cancer cells from weak basic environment of normal cells, cell imaging experiments 
of HPL-1 at pH 6.5 and 7.4 were performed. As shown in Fig. 3, the fluorescence 
intensity of HPL-1 in the cells with medium pH of 6.5 was about 4 times that of HPL-
1 in the cells with medium pH of 7.4, being consistent with the fluorescence spectra in 
vitro. This result suggests that HPL-1 can be used to accurately distinguish cancer cell 
micro-environment (pH 6.5) from normal cell micro-environment (pH 7.4). 
 
Fig. 3. Fluorescence imaging of HPL-1 (20 μM) in HepG2 cells treated with pH 6.5 and pH 7.4 
Britton−Robinson (BR) buffer solutions for 30 min, respectively. Scale bar: 10 μm. 
3.3. Cell imaging of HPL-1 in normal liver cells (L02) and hepatocellular 
carcinoma cells (HepG2 cell) 
Next, we conducted a comparative cell imaging experiment of HPL-1 in normal liver 
cells (L02) and cancerous liver cells (HepG2) to identify whether HPL-1 can accurately 
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distinguish cancerous liver cells from normal liver cells. As shown in Fig. 4, the 
fluorescence intensity of HPL-1 in HepG2 cells was about 6 times that of HPL-1 in 
normal liver cells (L02), implying that HPL-1 can be used to accurately distinguish 
cancerous liver cells from normal liver cells. When Fig. 3 and Fig. 4 are compared, the 
relative fluorescence intensity of HepG2 cells at pH 7.4 (~5) is stronger than that of 
L02 cells at pH 7.4 (~3), showing that HepG2 cells with high expression of ASGPR are 
more favourable for the endocytosis of HPL-1 with a galactose group while L02 cells 
with low expression of ASGPR uptake less HPL-1. This is suggested that the 
expression of ASGPR is one influencing factor to cause the different uptake amount of 
HPL-1, resulting in the fluorescence difference of HPL-1. On the other hand, the 
relative fluorescence intensity of HepG2 cells at pH 6.5 (~20) is much stronger than 
that of HepG2 cells at pH 7.4 (~5), suggesting that the different pH value is the more 
important influencing factor to cause the fluorescence difference of HPL-1. This may 
be because HPL-1 adopts a non-conjugated closed-ring lactam conformation with weak 
fluorescence at pH 7.4, and adopts an extended conjugated system with strong 
fluorescence at pH 6.5. On the whole, the significant difference of fluorescence 
intensity between HepG2 cells and L02 cells is simultaneously caused by the different 
expressions of ASGPR and the different pH values.   
 
Fig. 4. Fluorescence imaging of HPL-1 (20 μM) in HepG2 cells (medium pH 6.5) and L02 cells 
(medium pH 7.4). FI: Fluorescence intensity, Scale bar: 10 μm. 
3.4. Cell imaging of HPL-1 in hepatocellular carcinoma cells (HepG2 cell) and 
other tissue cells 
We then performed hepatocyte-targeting cell imaging experiments to exploit whether 
HPL-1 is able to selectively distinguish hepatocellular carcinoma cells from other 
tissue cells (Fig. 5). It was found that although all of these cells showed green 
fluorescence, the fluorescence intensity of the HepG2 cell was about 6 times that of 
A549 cell, 15 times that of SGC-7901, and 12 times that of HeLa. These results suggest 
that HPL-1 has good hepatocyte-targeting and could selectively distinguish 
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hepatocellular carcinoma cells from other tissue cells. The reason can be attributed to 
a fact that HepG2 cells with high expression of ASGPR possesses stronger 
phagocytosis capacity toward HPL-1 with a galactose group than A549, SGC-7901 and 
Hela cells with low expression of ASGPR, thus causing the fluorescence difference of 
Cells. The difference in fluorescence intensity between A549, SGC-7901 and Hela cells 
can be also attributed to their difference of expression amounts of ASGPR under the 
same pH value. 
 
Fig. 5. Fluorescence imaging of HPL-1 (20 μM) in HepG2, A549, SGC-7901 and HeLa cells treated 
with pH 6.5 BR buffer solutions for 30 min. FI: Fluorescence intensity, Scale bar: 10 μm. 
3.5. The contribution of the HPL-1 fragment on liver-targeting capacity 
To probe the role of key fragments of HPL-1 on hepatocyte-targeting capacity, two 
representative compounds 3 without phosphate group and gatactose group, 
Compound 6 with phosphate group were prepared comparatively analyzed. As shown 
in Fig. 6, the fluorescence intensity of Compound 6 was stronger than that of compound 
3, indicating that the phosphate modification is beneficial for the hepatocyte-targeting 
strategy. The fluorescence intensity of HPL-1 is significantly stronger than that of 
compound 6, suggesting that the introduction of galactose group is favourable for 
hepatocyte-targeting capacity, which is attributed to the specific recognization of the 
galactose unit of HPL-1 on ASGPR overexpressed on the hepatocytes. Furthermore, 
HPL-1 exhibited much higher fluorescence intensity than Compound 3 and 
Compound 6，showing that the co-modification with phosphate and galactose groups 
could synergistically improve hepatocyte-targeting effect of compounds, which is 
attributed to the superposition effect of phosphate and galactose.  
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Fig.6. Fluorescence imaging of Compound 3, Compound 6 and HPL-1 (20 μM) in HepG2 cells 
treated with pH 6.5 BR buffer solutions for 30 min. FI: Fluorescence intensity, Scale bar: 10 μm. 
3.6. Galactose inhibition test 
To further illuminate the contribution of galactose on the hepatocyte-targeting 
capacity of HPL-1, we performed galactose competition experiments. As shown in Fig. 
7, the fluorescence intensity of HPL-1 gradually decreased with the addition of 
galactose (0-40 μM), and the fluorescence can hardly be observed when galactose 
reached 40 μM. These results demonstrate that the specific recognition of galactose 
group on ASGPR is one of driving forces for the hepatocyte-targeting capacity of 
HPL-1. 
 
Fig. 7. Fluorescence imaging of HPL-1 in HepG2 cells pretreated with different doses of galactose. 
Scale bar: 10 μm. FI: Fluorescence intensity. 
Lysosome has been reported as an acid production center (pH 3.8-5.0) in living cells 
and may be directly related to an acidic micro-environment of cancer cells30. Therefore, 
it is very significant to illuminate whether HPL-1 can reach intracellular lysosome. In 
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Fig. 8, the cells showed the pseudo-green fluorescence of HPL-1 and the pseudo-red 
fluorescence of LysoTracker respectively. Furthermore, HPL-1 and LysoTracker were 
well merged in HepG2 cells with the Mander’s overlap coefficient of 0.94, suggesting 
that HPL-1 could specifically reach intracellular lysosomes, which may be attributed 
to the attraction of the lysosomal acidic micro-environment to the alkaline 
dimethylamino group of HLP-1. 
 
Fig. 8. Fluorescence imaging of HepG2 cells treated with 500 nM of LysoTracker (LT) and 20 μM 
of HPL-1. Merged image is the overlap of HPL-1 and LT. The fluorescence intensity correlation 
plots of LT and HPL-1 (grayscale value). 
3.7. Cytotoxicity 
Low toxicity is an important requirement for fluorescent probes used in biological 
systems. As shown in Fig. 9, after HepG2 cells were incubated with HPL-1 (<10 μM) 
for 24 hours, the cell viability was nearly 100%. Even when the concentration of HPL-
1 was increased to 20 μM, the cell viability was still above 80%. Clearly, HPL-1 could 
be harmlessly used to detect hepatoma cells in biological system. The possible reason 
is that HPL-1 contains biocompatible phosphate and galactose groups.  
 
Fig. 9. Cell viability of HepG2 incubated with different concentrations of HPL-1. 
The above results showed that compared with other pH fluorescent probes (Table 
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S1), HPL-1 possesses the most narrow detection range of pH (6.4-6.7), which 
corresponds to the pH range of cancer micro-environment. Moreover, HPL-1 showed 
excellent hepatocyte-targeting capacity (particularly for hepatoma cells). 
 
4. Conclusion 
A new dual hepatocyte-targeting fluorescent probe (HPL-1) has been developed in 
this study. This molecule switches on at tumorous micro-environment (pH 6.5), but 
switches off at physiological micro-environment (pH 7.4). HPL-1 can distinguish 
hepatoma cells from other tissue cells, and it represents the first example of small 
molecules for specific hepatoma cell targeting. The observed hepatocyte-targeting 
capacity trend with compounds 3, 6 and HPL-1 indicates that while phosphate 
modification is an efficient hepatocyte-targeting strategy, and co-modification with 
phosphate and the galactose unit could synergistically improve hepatocyte-targeting 
effect of compounds. More importantly, HPL-1 can precisely distinguish cancerous 
liver cells from normal liver cells via accurate response to adjacent tumorous and 
physiological pH. Moreover, the observed low-toxicity and ready availability of HPL-
1 are beneficial to the detection of hepatoma cells in vitro, and is of great significance 
for the early diagnosis and precise treatment of hepatocellular carcinoma.  
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